Cellular and Molecular Mechanisms for the Initiation and Progression of β Cell Destruction Resulting from the Collaboration Between Macrophages and T Cells

References

• Bach J. F. Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulation. J Autoimmun 1995; 8: 439–463
   PubMed Web of Science ®Google Scholar
• Rossini A. A., Greiner D. L., Friedman H. P., Mordes J. P. Immunopathogenesis of diabetes mellitus. Diabetes Rev 1993; 1: 43–75
   Google Scholar
• Yoon J. W., Park Y. H., Santamaria P. Autoimmunity of insulin-dependent diabetes. Drugs, diet and disease. Vol 2: Mechanistic approaches to diabetes, P. R. Flatt, C. Ioannides. Ellis Howard of Simon and Schuster International Group, London 1995; 57–97
   Google Scholar
• Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291–297
   PubMed Web of Science ®Google Scholar
• Marliss E., Nakhooda A., Poussier P., Simma A. The diabetic syndrome of the 'BET Wistar rat: Possible relevance to type I (insulin-dependent) diabetes in man. Diabetologia 1982; 22: 225–232
   PubMed Web of Science ®Google Scholar
• Rossini A. A., Mordes J. P., Handler E. S. Speculations on etiology of diabetes mellitus: Tumbler hypothesis. Diabetes 1988; 37: 257–261
   PubMed Web of Science ®Google Scholar
• Marliss E. B. The Juvenile Diabetes Foundation workshop on spontaneously diabetic BB rat as potential for insight into human juvenile diabetes. Metab Clin Exp 1983; 32: 1–166
   PubMedGoogle Scholar
• Like A. A., Rossini A. A., Appel M. C, Guberski D. L., Williams R. M. Spontaneous diabetes mellitus: Reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 1979; 206: 1421–1423
   PubMed Web of Science ®Google Scholar
• Like A. A., Biron C. A., Weringer E. J., Byman K., Sroczynsaki E., Guberski D. L. Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T-lymphocytes or natural killer cells. J Exp Med 1986; 164: 1145–1159
   PubMed Web of Science ®Google Scholar
• Makino S., Kunimoto K., Munaoko Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese diabetic strain of mice. Exp Anim 1980; 29: 1–13
   PubMedGoogle Scholar
• Kolb H., Kantwerk G., Treichel U., Kurner T., Kiesel U., Hoppe T. Prospective analysis of islet lesions in BB rats. Diabetologia 1986; 29: A559
   Google Scholar
• Lee K., Kim M., Amano K., Pak C, Jarworski M., Mehta J. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 1988; 37: 1053–1058
   PubMed Web of Science ®Google Scholar
• Voorbij H., Jeucken P., Kabel P., DeHaan M., Drexhage H. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 1989; 38: 1623–1629
   PubMed Web of Science ®Google Scholar
• Walker R., Bone A., Cooke A., Baird J. Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats: Possible role for macrophages in the pathogenesis of IDDM. Diabetes 1988; 37: 1301–1304
   PubMed Web of Science ®Google Scholar
• Jasen A., Homo-Delarche F., Hooijkaas H., Leenen P. J., Dardenne M., Drexhage H. A. Immunohisto-chemical characterization of monocyte-macrophages and dendritic cells involved in the initiation of insulitis and beta-cell destruction in NOD mice. Diabetes 1994; 43: 667–675
   PubMedGoogle Scholar
• Ziegler A. G., Erhard J., Lampeter E. F., Nagelkerken L. M., Standi E. Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun 1992; 5: 571–579
   PubMedGoogle Scholar
• Lee K., Pak C, Amano K., Yoon J. W. Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the deletion of macrophages. Diabetologia 1988; 31: 400–402
   PubMedGoogle Scholar
• Lee K., Amano K., Yoon J. W. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 1988; 37: 989–991
   PubMed Web of Science ®Google Scholar
• Oschilewski U., Kiesel U., Kolb H. Administration of silica prevents diabetes in BB rats. Diabetes 1985; 34: 197–199
   PubMed Web of Science ®Google Scholar
• Unuaue E. R. Antigen-presenting function of the macrophage. Ann Rev Immunol 1984; 2: 395–428
   PubMedGoogle Scholar
• Unuaue E. R., Allen P. M. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987; 236: 551–557
   PubMedGoogle Scholar
• Yoon J. W., Jun H. S., Utsugi T. Initiation of autoimmune type I diabetes and its possible prevention. Diabetes 1994, S Baba, T. Kaneko. Elsevier Scientific Publishers, Amsterdam 1995; 116–126
   Google Scholar
• Nagata M., Yoon J. W. Studies on autoimmunity for initiation of beta cell destruction: IX. Electron microscopic evidence on a distinct difference in the destruction of beta cells between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 1992; 41: 998–1008
   PubMedGoogle Scholar
• Ihm S. H., Yoon J. W. Studies on autoimmunity for the initiation of beta cell destruction: VI. Macrophages are essential for the development of beta cell specific cytotoxic effectors and insulitis in nonobese diabetic (NOD) mice. Diabetes 1990; 39: 1273–1278
   PubMed Web of Science ®Google Scholar
• Amano K., Yoon J. W. Studies on autoimmunity for the initiation of beta cell destruction: V. Decrease of macrophage-dependent T-lymphocytes and NK cytotoxicity in silica-treated DP-BB rats. Diabetes 1990; 39: 590–596
   PubMedGoogle Scholar
• Gepts W. Islet changes in human diabetes. The Islets of Langerhans: Biochemistry, Physiology, and Pathology, S. J. Cooperstein, D. Watkins. Academic Press, New York 1981; 321–356
   Google Scholar
• Foulis A. K., Liddle C. N., Farquharson M. A., Richmond J. A., Weir R. S. The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: A 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267–274
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F., Dean B. M., McNally J. M., McKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomenon and expression of HLA molecules in the pancreas of diabetic insulitis. N Engl J Med 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. Clin Invest 1992; 90: 1901–1910
   Google Scholar
• Sibley R. K., Sutherland D. E., Goetz F., Michael A. F. Recurrent diabetes mellitus in the pancreas iso-and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53: 132–144
   PubMed Web of Science ®Google Scholar
• Santamaria P., Nakhleh R. E., Sutherland D. E., Barbosa J. J. Isolation and characterization of T lymphocytes infiltrating a human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 1992; 41: 53–61
   PubMed Web of Science ®Google Scholar
• Santamaria P., Lewis C, Jessurun J., Sutherland D. E., Barbosa J. J. Skewed T cell receptor usage and junctional heterogeneity among isletitis αβ and γδ T cells in human type I diabetes. Diabetes 1994; 43: 599–606
   PubMed Web of Science ®Google Scholar
• Like A. A., Kislauskis E., Williams R. M., Rossini A. A. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BBAV rat. Science 1982; 216: 644–646
   PubMed Web of Science ®Google Scholar
• Like A. A., Anthony M., Guberski D. L., Rossini A. A. Spontaneous diabetes in the BBAV rat: Effects of glucocorticoids, cyclosporin-A and antiserum to rat lymphocytes. Diabetes 1983; 32: 326–330
   PubMedGoogle Scholar
• Koevary S., Rossini A. A., Stroller W., Chick W. Passive transfer of diabetes in the BB/W rat. Science 1983; 220: 727–728
   PubMed Web of Science ®Google Scholar
• Edouard P., Hiserodt J. C, Plamondon C., Poussier P. CD8+ T cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes 1993; 42: 390–397
   PubMed Web of Science ®Google Scholar
• Miyazaki A., Hanafusa T., Yamada K., Miyagawa J., Fujino-Kurihara H., Nakajima H. Predominance of T lymphocytes in pancreatic islets and spleen of prediabetic nonobese diabetic (NOD) mice: A longitudinal study. Clin Exp Immunol 1985; 60: 622–630
   PubMed Web of Science ®Google Scholar
• Koike T., Itoh Y., Ishii T., Takabayashi K., Maruyama N., Tomioka H. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987; 36: 539–541
   PubMed Web of Science ®Google Scholar
• Ogawa M., Maruyama T., Hasegawa T., Kanaya T., Kobayashi F., Tochino Y. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in nonobese diabetic (NOD) mice. Biomed Res 1985; 6: 103–105
   Google Scholar
• Dardenne M., Lepault F., Bendelac A., Bach J. F. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 1989; 19: 889–895
   PubMed Web of Science ®Google Scholar
• Makino S., Harada M., Kishimoto Y., Hayashi Y. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim 1986; 35: 495–489
   Google Scholar
• Christianson S. W., Shultz L. D., Leiter E. H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NON-Thy-1 a donors. Diabetes 1993; 42: 44–55
   PubMed Web of Science ®Google Scholar
• Mori Y., Suko M, Okudaira H., Matsuba I., Tsu-Ruoka A., Sasaki A. Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 1986; 29: 244–247
   PubMed Web of Science ®Google Scholar
• Harada M., Makino S. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1,2 antibody. Exp Anlm 1986; 35: 501–504
   PubMed Web of Science ®Google Scholar
• Shizuru J. A., Taylor-Edwards C, Banks B. A., Gregory A. K., Fathman C. G. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T helper lymphocytes. Science 1988; 240: 659–662
   PubMed Web of Science ®Google Scholar
• Hayward A. R., Shreiber M. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol 1989; 143: 1555–1559
   PubMed Web of Science ®Google Scholar
• Semp P., Bedossa P., Richard M. F., Villa M. C, Bach J. F., Biotard C. Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol 1991; 21: 1163–1169
   PubMedGoogle Scholar
• Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855–860
   PubMed Web of Science ®Google Scholar
• Bendelac A., Carnaud C, Biotard C., Bach J. F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. J Exp Med 1987; 166: 823–832
   PubMed Web of Science ®Google Scholar
• Miller B. J., Appel M. C, O'Neil J. J., Wicker L. S. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988; 140: 52–58
   PubMed Web of Science ®Google Scholar
• Haskins K., Portas M., Bergman B., Lafferty K., Bradley B. Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989; 86: 8000–8004
   PubMed Web of Science ®Google Scholar
• Haskins K., McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 249: 1433–1436
   PubMed Web of Science ®Google Scholar
• Reich E. P., Sherwin R. S., Kanagawa O., Janeway C. A. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989; 341: 326–328
   PubMed Web of Science ®Google Scholar
• Nakano N., Kikutani H., Nishimoto H., Kishimoto T. T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in nonobese diabetic mice. J Exp Med 1991; 173: 1091–1097
   PubMed Web of Science ®Google Scholar
• Pankewycz O., Strom T. B., Rubin-Kelly V. E. Islet-infiltrating T cell clones from nonobese diabetic mice that promote or prevent accelerated onset diabetes. Eur J Immunol 1991; 21: 873–879
   PubMed Web of Science ®Google Scholar
• Yagi H., Matsumoto M., Kunimoto K., Kawaguchi J., Makino S., Harada M. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 1992; 22: 2387–2393
   PubMed Web of Science ®Google Scholar
• Bradley B. J., Haskins K., LaRosa F. G., Lafferty K. J. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T cell clone. Diabetes 1992; 41: 1603–1608
   PubMedGoogle Scholar
• Nagata M., Santamaria P., Kawamura T., Utsugi T., Yoon J. W. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta cells in NOD mice. J Immunol 1994; 152: 2042–2050
   PubMed Web of Science ®Google Scholar
• Daniel D., Gill R. G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25: 1056–1062
   PubMed Web of Science ®Google Scholar
• Reich E. P., Scaringe D., Yagi J., Sherwin R. S., Janeway C. A. Prevention of diabetes in NOD mice by injection of autoreactive T lymphocytes. Diabetes 1989; 38: 1647–1651
   PubMedGoogle Scholar
• Hayakawa M., Yokono K., Nagata M., Hatamori N., Ogawa W., Miki A. Morphological analysis of selective destruction of pancreatic beta cells by cytotoxic T lymphocytes in NOD mice. Diabetes 1991; 40: 1210–1217
   PubMedGoogle Scholar
• Taki T., Nagata M., Ogawa W., Hatamori N., Hayakawa M., Hari J. Prevention of cyclophos-phamide-induced and spontaneous diabetes in NOD/Shi/ Kbe mice by anti-MHC class I Kd monoclonal antibody. Diabetes 1991; 40: 1203–1209
   PubMedGoogle Scholar
• Matsumoto M., Yagi H., Kunimoto K., Kawaguchi J., Makino S., Harada M. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: The roles of T cell subsets in the pathogenesis. Cell Immunol 1993; 148: 1723–1730
   Google Scholar
• Shimizu J., Kanagawa O., Unanue E. R. Presentation of beta cell antigens to CD4+ and CD8+ T cells of nonobese diabetic mice. J Immunol 1993; 151: 1723–1730
   PubMedGoogle Scholar
• Wegmann D., Norbury-Glaser M., Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur J Immunol 1994; 24: 1853–1857
   PubMed Web of Science ®Google Scholar
• Bendelac A., Boitard C., Bedossa P., Bazin H., Bach J. F. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B-lymphocytes. J Immunol 1988; 141: 2625–2628
   PubMed Web of Science ®Google Scholar
• Thivolet C, Bendelac A., Bedossa P., Bach J. F., Carnaud C. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol 1991; 146: 85–88
   PubMed Web of Science ®Google Scholar
• Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., Cooke A. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 1990; 348: 639–642
   PubMed Web of Science ®Google Scholar
• Lo D., Reilly C, Scott B., Liblau R., McDevitt H., Burkly L. Antigen-presenting cells in adoptively transferred spontaneous autoimmune diabetes. Eur J Immunol 1993; 23: 1693–1698
   PubMed Web of Science ®Google Scholar
• Katz J., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185–1188
   PubMed Web of Science ®Google Scholar
• Peterson J. D., Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 1996; 45: 328–336
   PubMed Web of Science ®Google Scholar
• Haskins K., Portas M., Bradley B., Wegmann D., Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 1988; 37: 1444–1448
   PubMed Web of Science ®Google Scholar
• Katz J. D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993; 74: 1089–1100
   PubMed Web of Science ®Google Scholar
• Katz J., Benoist C., Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 1993; 23: 3358–3360
   PubMed Web of Science ®Google Scholar
• Wicker L. S., Leiter E. H., Todd J. A., Renjilian R. J., Peterson E., Fischer P. A. β2-microglo-bulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994; 43: 500–504
   PubMed Web of Science ®Google Scholar
• Santamaria P., Utsugi T., Park B. J., Averill N., Kawa-Zu S., Yoon J. W. Beta cell cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha chain CDR3 sequences. J Immunol 1995; 154: 2494–2503
   PubMed Web of Science ®Google Scholar
• Wong S., Visintin I., Wen L., Flavell R. A., Janeway C. A. CDS T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996; 183: 67–76
   PubMed Web of Science ®Google Scholar
• Utsugi T., Yoon J. W., Park B. J., Imamura M., Ave-Ril N., Kawazu S., Santamaria P. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived P cell cytotoxic CD8+ T cell clones in vivo. Diabetes 1996; 45: 1121–1131
   PubMed Web of Science ®Google Scholar
• Verdaguer J., Yoon J. W., Averill N., Utsugi T., Park B. J., Santamaria P. Acceleration of diabetes in NOD mice expressing beta cell-cytotoxic T cell-derived TcR/J transgene. J Immunol 1996; 157: 4726–4735
   PubMed Web of Science ®Google Scholar
• Chervonsky A. V, Wang Y., Wong F. S., Visintin I., Flavell R. A., Janeway C. A. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17–24
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nielsen J. H., Ben-Dixen G., Nerup J. Cytokines cause functional and structural damage to isolated islet of Langer-hans. Allergy 1985; 40: 424–429
   PubMed Web of Science ®Google Scholar
• Pankewycz O. G., Guan J. X., Benedict J. F. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocrine Rev 1995; 16: 164–176
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M. Cytotoxicity of human p 17 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Sandler S., Eizirik D. L., Svensson C, Strandell E., Welsh M., Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 1991; 10: 241–253
   PubMed Web of Science ®Google Scholar
• Wogensen L. D., Reimers J., Mandrup-Poulsen T., Nerup J. Recombinant human interleukin-1β (IL-I) induces a transient diabetic state in normal rats. Diabetes 1991; 40: 117A
   Google Scholar
• Eizirik D. L., Tracey D. E., Bendtzen K., Sandler S. An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia 1991; 34: 445–448
   PubMed Web of Science ®Google Scholar
• Hughes J. H., Colca J. R., Easom R. A., Turk J., McDaniel M. L. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
   PubMed Web of Science ®Google Scholar
• Helqvist S., Zumsteg U. W., Spinas G. A., Palmer J. P., Mandrup-Poulsen T., Egeberg J. Repetitive exposure of pancreatic islets to interleukin-1β. An in vitro, model of prediabetes?. Autoimmunity 1991; 10: 311–318
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Egeberg J., Nerup J., Bendtzen K., Nielsen J. H., Dinarello C. A. Ultrastructural studies of time course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand C 1987; 95: 55–63
   PubMedGoogle Scholar
• Mandrup-Poulsen T., Bendtzen K., Dinarello C A., Nerup J. Human tumour-necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta cell-cytotoxicity. J Immunol 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Southern D., Schulster D., Green I. C. Inhibition of insulin secretion by interleukin 1-β and tumor necrosis factor-a via an L-arginine-dependent nitric oxide generation mechanism. FEBS Lett 1990; 276: 42–44
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Pukel C, Baquerizo H., MacKay P. Immunological mechanisms of islet β cell destruction: Cytotoxic cells and cytokines. Frontiers in Diabetes Research. Lessons from Animal Diabetes II, E. Shafrir, A. E. Reynolds. John Libbey and Co., London 1988; 52–57
   Google Scholar
• Appels B., Burkart V., Kantwerk-Funke M., Funda J., Kolb-Bachofen V., Kolb H. Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol 1989; 142: 3803–3808
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H., Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133–136
   PubMed Web of Science ®Google Scholar
• Sandler S., Bendtzen K., Eizirik D L., Welsh M. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinol 1990; 126: 1288–1294
   PubMed Web of Science ®Google Scholar
• Corbett J. A., McDaniel M. L. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 1995; 181: 559–568
   PubMedGoogle Scholar
• Jiang Z., Woda B. A. Cytokine gene expression in the islets of the diabetic BioBreeding/Worcester rat. J Immunol 1991; 146: 2990–2994
   PubMed Web of Science ®Google Scholar
• Welsh M., Welsh N., Bendtzen K., Mares J., Standell E., Oberg C. Comparison of mRNA contents of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia 1995; 38: 153–160
   PubMed Web of Science ®Google Scholar
• Trembleau S., Penna G., Bosi E., Mortara A., Gately M. K., Adorini L. IL-12 administration induces Thl cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995; 181: 817–821
   PubMed Web of Science ®Google Scholar
• Zipris D., Greiner D. L., Malkani S., Whalen B., Mordes J. P., Rossini A. A. Cytokine gene expression in islets and thyroids of BB rats –IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 1996; 156: 1315–1321
   PubMed Web of Science ®Google Scholar
• Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37: 1154–1158
   PubMed Web of Science ®Google Scholar
• Somoza N., Vargas F., Roura-Mir C, Vives-Pi M., Fernandez-Figueras M. T., Ariza A. Pancreas in recent onset insulin-dependent diabetes mellitus: Changes in HLA, adhesion molecules and autoantigens, restricted T receptor V/i usage, and cytokine profile. J Immunol 1994; 153: 1360–1372
   PubMed Web of Science ®Google Scholar
• Berman M. A., Sandborg C. I., Wang Z., Imt'eld K. L., Zaldivar F., Dadufalza V. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157: 4690–4696
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Sorenson O., Suarez-Pinzon W. L., Power R. F., Rajotte R. V., Bleackley R. C. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlates with graft rejection and interleukin 10 with graft survival. Diabetologia 1994; 37: 833–837
   PubMedGoogle Scholar
• Hancock W. W., Polanski M, Zhang J., Blogg N., Weiner B. L. Suppressioon of insulitis in nonobese diabetic (NOD) mice by oral administration is associated with selective expression of interleukin-4 and-10, transforming growth factor-/} and prostaglandin-E. Am J Pathol 1995; 147: 1193–1199
   PubMed Web of Science ®Google Scholar
• Tian J., Atkinson M. A., Clare-Salzer M., Hershen-Feld A., Forsthubler T., Lehmann P. V. Nasal administration of glutamate decarboxylase (GAD 65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996; 183: 1561–1567
   PubMed Web of Science ®Google Scholar
• Kolb K., Zielasek J., Treichel U., Freytag G., Wrann M., Kiesel U. Recombinant interleukin-2 enhances spontaneous insulin-dependent diabetes in BB rats. Eur J Immunol 1986; 16: 209–212
   PubMed Web of Science ®Google Scholar
• Burstein D., Handler E. S., Sehindler J., Seals J., Mordes J. P., Rossini A. A. Effect of interleukin-2 on diabetes in the BB/Wor rat. Diabetes Res 1987; 5: 163–167
   PubMedGoogle Scholar
• Serreze D. V., Hamaguchi K., Leiter E. H. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 1989; 2: 759–776
   PubMed Web of Science ®Google Scholar
• Allison J., Malcom L., Chosich N., Miller J. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells. Eur J Immunol 1992; 22: 1115–1121
   PubMedGoogle Scholar
• Debray-Sachs M., Carnaud C, Boitard C, Cohen H., Gresser I., Bedossa P. Prevention of diabetes in NOD mice treated with antibody to murine IFN-y. J Autoimmun 1991; 4: 237–248
   PubMed Web of Science ®Google Scholar
• Sarvetnick N., Liggitt D., Pitts S., Hansen S., Stewart T. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773–782
   PubMed Web of Science ®Google Scholar
• Hultgren B., Huang X., Dybdal N., Stewart T. A. Genetic absence of y-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996; 45: 812–817
   PubMed Web of Science ®Google Scholar
• Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169–175
   PubMedGoogle Scholar
• Mueller R., Krahl T., Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996; 184: 1093–1099
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Suarez-Pinzon W., El-Sheikh A., Soren-Sen O., Power R. F. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Thl cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes 1996; 45: 749–754
   PubMed Web of Science ®Google Scholar
• Fox C. J., Danska J. S. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 1997; 158: 2414–2424
   PubMed Web of Science ®Google Scholar
• Wogensen L., Lee M., Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379–1384
   PubMed Web of Science ®Google Scholar
• Asayama K., Kooy N. W., Burr I. M. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets; decrease of islet manganosuperoxide dismutase. J Lab Clin Med 1986; 107: 4559–4564
   Google Scholar
• Malaisse W. J., Malaisse-Lagae F., Sener A., Pipeleers D. G. Determinants of the selective toxicity of alloxan to the pancreatic β cell. Proc Natl Acad Sci USA 1982; 79: 927–930
   PubMed Web of Science ®Google Scholar
• Corbett J. A., McDaniel M. L. Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897–903
   PubMed Web of Science ®Google Scholar
• Faust A., Kleemann R., Rothe H., Kolb H., Shafrir E. Role of macrophages and cytokines in β cell death. Lessons from animal diabetes VI. Birkhauser Boston, Cambridge 1996; 47–56
   Google Scholar
• McDaniel M. L., Kwon G., Hill J. R., Marshall C. A., Corbett J. A. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 1996; 211: 24–32
   PubMed Web of Science ®Google Scholar
• Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–1624
   PubMed Web of Science ®Google Scholar
• Kleemann R., Rothe H., Kolb-Bachofen V., Xie Q. W., Nathan C, Martin S. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 1993; 328: 9–12
   PubMed Web of Science ®Google Scholar
• Linsay R. M., Smith W., Rossiter S. P., McIntyre M. A., Williams B. C., Baird J. D. N Omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 1995; 44: 365–368
   PubMedGoogle Scholar
• Bowman M., Simell O., Look Z., Luchetta R., Atkinson M. Pharmokinetic and therapeutic analysis of aminoguanidine. Diabetes 1994; 43: 235A
   Google Scholar
• Ko I. Y., Ihm S. H., Yoon J. W. Studies on autoimmunity for initiation of beta-cell destruction VIII. Pancreatic beta cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats. Diabetologia 1991; 34: 548–554
   PubMedGoogle Scholar
• Ko I. Y., Jun H. S., Kim G. S., Yoon J. W. Studies on autoimmunity for initiation of beta-cell destruction X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the BB rat. Diabetologia 1994; 37: 460–465
   PubMed Web of Science ®Google Scholar
• Yoon J. W. A new look at viruses in type I diabetes (Invited Review). Diabetes Me tab Rev 1995; 11: 83–107
   PubMedGoogle Scholar
• Yoon J. W. The role of viruses in the pathogenesis of IDDM. Diabetes Mellitus: A Fundamental and Clinical Text, S. L. Taylor. JB Lippincott, Philadelphia 1996; 338–348
   Google Scholar